Table 2 Number of people (%) with type 2 diabetes and different types of treatment, including a) non-secretagogues e.g. metformin, pioglitazone, DPP-4 inhibitor, SGLT-2 inhibitor, GLP-1 agonist; b) secretagogues e.g. sulfonylureas and glinides; and insulin treated type 2 diabetes
Group of people with type 2 diabetes | Number of people (%) | Proportion difference (95% CI) | P value | |
|---|---|---|---|---|
June 1997 – May 1998 (n = 7678) | 1 Jan 2011–31 Dec 2012 (n = 21,734) | |||
a) | 3954 (51.5%) | 12,812 (58.9%) | 0.075 (0.062–0.087) | < 0.001 |
b) | 2823 (36.8%) | 4859 (22.4%) | −0.144 (−0.156 – −0.132) | < 0.001 |
Insulin | 901 (11.7%) | 4063 (18.7%) | 0.070 (0.061–0.078) | < 0.001 |